ctrl K

Watchlist Price Alert

Centessa Pharmaceuticals (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

12.63

0.03 (0.24%)

At close: Jun 17, 2025, 10:44 AM

Centessa Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	383.22M	128.03M	393.64M	595.08M	7.23M
Short-Term Investments	98.96M	128.52M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.05M	2.55M	45.98M	34.39M	552K
Receivables	45.3M	39.15M	26.72M	16.81M	n/a
Inventory	n/a	n/a	-29.99M	-17.81M	1M
Other Current Assets	1.78M	1.62M	3.27M	993K	3.93M
Total Current Assets	536.41M	315.09M	393.64M	595.08M	11.16M
Property-Plant & Equipment	11.76M	12.95M	1.17M	162K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	40.39M	45.15M	50.66M	34.55M	552K
Total Assets	576.8M	360.25M	444.31M	629.63M	11.72M
Account Payables	7.14M	11.81M	13.84M	7.3M	1.03M
Deferred Revenue	n/a	n/a	n/a	n/a	1.04M
Short-Term Debt	n/a	n/a	n/a	n/a	5.63M
Other Current Liabilities	10.18M	839K	2.27M	871K	922K
Total Current Liabilities	58M	39.38M	38.34M	24.64M	8.62M
Long-Term Debt	108.94M	75.7M	69.8M	75.7M	n/a
Other Long-Term Liabilities	29K	29K	n/a	37.74M	n/a
Total Long-Term Liabilities	117.25M	84.62M	108.14M	138.08M	25.52M
Total Liabilities	175.25M	124M	108.14M	138.08M	34.14M
Total Debt	117.23M	84.59M	69.8M	75.7M	5.63M
Common Stock	359K	273K	265K	252K	21K
Retained Earnings	-988.7M	-752.95M	-601.86M	-385.65M	-22.42M
Comprehensive Income	4.21M	1.49M	-1.5M	688K	-86K
Shareholders Equity	401.55M	236.24M	336.17M	491.55M	-22.42M
Total Investments	98.96M	128.52M	n/a	n/a	n/a